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A B S T R A C T
Several studies have suggested that bone marrow stromal steam cells (BMSC) exist in a quiescent state (G0)
within the in vivo niche; however, an explicit analysis of the biology of G0 state-BMSC has not been reported. We
hypothesized that induction of G0 in BMSC might enhance their stem cell properties. Thus, we induced quies-
cence in BMSC in vitro by (a) suspension culture in a viscous medium or (b) culture on soft polyacrylamide
substrate; and examined their molecular and functional phenotype. Induction of G0 was conﬁrmed by bromo-
deoxyuridine (BrdU) labelling and analysis of cell cycle gene expression. Upon reactivation and re-entry into cell
cycle, G0 state-BMSC exhibited enhanced clonogenic self-renewal, preferential diﬀerentiation into osteoblastic
rather than adipocytic cells and increased ectopic bone formation when implanted subcutaneously in vivo in
immune-deﬁcient mice, compared to asynchronous proliferating (pre-G0) BMSC. Global gene expression pro-
ﬁling revealed reprogramming of the transcriptome during G0 state including signiﬁcant alterations in relevant
pathways and expression of secreted factors, suggesting altered autocrine and paracrine signaling by G0 state-
BMSC and a possible mechanism for enhanced bone formation. G0 state-BMSC might provide a clinically re-
levant model for understanding the in vivo biology of BMSC.
1. Introduction
Cellular quiescence (G0) is an intrinsic property of adult stem cells
(ASC) in vivo that allows suppression of cell division and tissue-speciﬁc
genetic programs without aﬀecting the capacity for cell cycle re-entry
and subsequent diﬀerentiation (Cheung and Rando, 2013,
Subramaniam et al., 2013, Rumman et al., 2015). Earlier studies de-
monstrated that bone marrow stromal cells (BMSC) in vivo display
characteristics of G0 state, as they are label-retaining and resistant to 5-
ﬂuorouracil (5-FU)-induced apoptosis (Haas et al., 1969). More re-
cently, a subset of label-retaining cells was identiﬁed in mouse
periosteum and found to co-express BMSC markers (Cherry et al.,
2014). In addition, subpopulation of freshly isolated PDGFRα(+) SCA-
1(+) murine BMSC were found to be in G0 state as assessed by DNA
and RNA content (Morikawa et al., 2009). However, information re-
garding the functional characteristics of G0 BMSC has not been re-
ported.
BMSC (also known as bone marrow skeletal stem cells or me-
senchymal stem cells) represent a population of plastic adherent cells
isolated from bone marrow aspirates (Zaher et al., 2014, Bianco and
Robey, 2015) and exhibit regeneration-enhancing characteristics upon
transplantation in a number of in vivo disease models such as bone
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fracture (Granero-Molto et al., 2009), ischemic heart disease (Cai et al.,
2016), liver injury (Wang et al., 2016). However, little is known about
the biology of G0 BMSC, and many inferences are based on studies of
BMSC in culture may not be appropriate since proliferating plastic-
adherent cells diﬀer in key regulatory properties from the G0 state that
predominates in adult stem cells in vivo (Morikawa et al., 2009; Li
et al., 2014).
As a ﬁrst step in understanding the biology of quiescent BMSC, we
examined the eﬀect of inducing the G0 state on stem cell and diﬀer-
entiation functions in culture. In a number of cellular models, induction
of G0 causes signiﬁcant changes in cellular and molecular functions of
the cells (Pallafacchina et al., 2010; Mourikis et al., 2012). Thus, we
induced G0 in BMSC using two approaches: suspension culture in me-
thylcellulose (MC) and culture on soft polyacrylamide (PAA) substrates
and we examined the impact on BMSC stemness and changes in tran-
scriptome as compared to cultured asynchronous proliferating (pre-G0)
BMSC. Our results demonstrate that both these methods are eﬃcient in
inducing G0 state in BMSC and led to enhanced self-renewal ability,
osteoblastic diﬀerentiation and ectopic bone formation upon trans-
plantation in vivo. These changes were associated with signiﬁcant
changes in global gene expression inducting upregulation of in-
tracellular signaling pathways known regulate osteoblast diﬀerentia-
tion and bone formation. We conclude that induction of quiescence in
cultured BMSC provides a useful model for analysis of mechanisms that
might be relevant to the biology of BMSC in vivo.
2. Materials and methods
2.1. Cell culture
Both human and mouse cells were employed. The hBMSC-TERT cell
line which is a proven model for primary hBMSC due its stable phe-
notype (Simonsen et al., 2002; Twine et al., 2018) was used for tran-
scriptome analysis. Primary human and mouse BMSC were used to
corroborate the results obtained in hBMSC-TERT cells (Supplementary
Table 1).
Human bone marrow stromal stem cells (hBMSC) (from healthy
donors) were purchased from Texas A&M Health and Science Centre
(Texas, USA) and used between passages 1–3. hBMSC-TERT were de-
rived in Prof. Moustapha Kassem's laboratory by overexpressing human
TERT (telomerase reverse transcriptase) gene in hBMSC (Simonsen et al.,
2002). Mouse bone marrow stromal stem cells (mBMSC) were isolated
from 8-week old C57BL/6 mouse hind limb bones as described previous
(Soleimani and Nadri, 2009). BMSC were maintained as asynchronous
proliferating cultures (pre-G0) in growth medium (MEM-alpha, 10%
fetal bovine serum (FBS), penstrep, glutamax) (Gibco) and passaged at
60–70% conﬂuency. 2% methylcellulose (MC) (Sigma) stock used for
suspension culture was prepared as described previously (Arora et al.,
2017). To induce G0 in MC suspension culture, asynchronously pro-
liferating (pre-G0) BMSC were trypsinized and re-suspended in MC at a
density of 106 cells per 10ml of suspension medium and cultured for
48 h. Brieﬂy, for preparing 10ml MC suspension, 106 cells were col-
lected in 500 μl of growth medium in 50ml falcon, to which was added
FBS (10%), penstrep, glutamax, HEPES (10mM, pH 7.3) and 2% MC
(up to 10ml, ﬁnal MC concentration 1.3%). For reactivation studies,
MC cell suspension was diluted with 40ml PBS (pre-warmed at 37 °C),
centrifuged at 1800g for 30 mins at room temperature without brakes,
the supernatant discarded and the loose pellet dispersed by gentle pi-
petting. Cells were washed twice with 40ml of warm PBS, ﬁrst at 800 g
for 15min, and then at 250 g for 5min (Arora et al., 2017). This harvest
procedure yielded optimal viability. The harvested cells were counted
and checked for viability using trypan blue before replating on tissue
culture plastic dishes or lysed directly for RNA and protein isolation.
Polyacrylamide gels (PAA) substrates of diﬀerent stiﬀness were
prepared by cross-linking 40% PAA and 2% bis-acrylamide solution
(BioRad) mixed at diﬀerent concentrations in PBS, as described
previously (Pelham and Wang, 1997). Details of the substrate pre-
paration and rigidity values for diﬀerent combinations of PAA and bis-
acrylamide were as described (Tse and Engler, 2010). Brieﬂy, the gels
were prepared between two parallel glass cover slips, one coated with
3-APTMS ((3-aminopropyl) trimethoxysilane) (Sigma) and the other
with octadecyl-trichlorosilane (Sigma), to render the cover slip re-
spectively adherent and non-adherent to gel. Following cross-linked
and gelling, the non-adherent plate was removed, and the gel was
coated with type I collagen (Advanced Biomatrix) using sulfo-SANPAH
(sulfosuccinimidyl 6-(4′-azido-2′-nitrophenylamino) hexanoate) based
conjugation (Yeung et al., 2005) under UV for 15min. Gels were wa-
shed with PBS and maintained under 50 μg/ml of type I collagen so-
lution at 4 °C overnight. The control cover slip was also coated with
Type 1 collagen. To avoid any eﬀect of support glass plate on cellular
mechano-sensing (Buxboim et al., 2010), we prepared thick gels
(~400 μm), by keeping the volume of the gel solution constant at
200 μl. To induce G0 on soft PAA gels, cells were seeded at low density
(1000 cells/cm2) to avoid any cell-cell mechano-signaling via matrix
(Reinhart-King et al., 2008) and cultured for 48 h in growth medium.
Before seeding cells, excess collagen was removed and the gel was
equilibrated in growth medium for 1 h. For reactivation studies, G0-
arrested BMSC were harvested by trypsinization from the gel, and re-
plated on tissue culture plastic in growth medium or lysed directly for
RNA and protein isolation.
2.2. Immunoﬂuorescent staining
Ki67 staining: Cells were ﬁxed in 4% buﬀered formalin and were
incubated overnight with Ki67 (Dako, 1:100) at 4 °C. After, cells were
washed and incubated with a ﬂuorescent secondary (Alexa Fluor, Life
Technologies, 1:1000) for 1 h at RT, before counterstaining with DAPI
(Sigma).
Actin & vimentin staining: hBMSC were ﬁxed with 4% paraf-
ormaldehyde (PFA), pH 7 in 1% Triton-X-100 (Sigma) (1:1) for 1min on
ice. Cells were then washed twice with cytoskeleton stabilizing buﬀer
(CSB) (60mM PIPES (piperazine-N,N′-bis(2-ethanesulfonic acid)),
27mM HEPES ((4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)),
10mM EGTA ((ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tet-
raacetic acid)), 4 mM magnesium sulphate (heptahydrate), pH 7), and
ﬁxed again with 4% PFA for 5 mins on ice. Cells were washed with CSB,
blocked with 1.5% BSA in 0.5% Triton X-100 for 30 mins on ice and
incubated with anti-vinculin antibody (Sigma, 1:400) overnight at 4 °C,
detected with Alexa Fluor-568 Rabbit anti-mouse antibody (Thermo,
1:1000). Actin was detected with Alexa Fluor-488 Phalloidin (Thermo,
1:400) and nuclei counterstained with Hoechst 33342, prior to imaging
on a laser scanning confocal microscope (LSM, Carl Zeiss).
BrdU staining: Cells were pulsed with 100 μM BrdU (Sigma) for 1 h
at 37 °C, then processed for detection of incorporated BrdU using anti-
BrdU antibody (DSHB, 1:100) as described (Dhawan and Helfman,
2004).
2.3. RNA isolation and qPCR
Cells were lysed in 1ml of TRIzol (Invitrogen) and total RNA was
isolated per the manufacturer's recommendations and as previously
published (Cheedipudi et al., 2015). RNA was quantiﬁed on nanodrop
spectrophotometer (Thermo Scientiﬁc), and cDNA prepared with 1 μg
of total RNA using Invitrogen SSIII RT kit as per manufacturer's pro-
tocol. Real time PCR was performed on ABI HT7000 and fold change
was calculated by 2-ΔΔCt method, using GAPDH to normalize values. List
of primers used is provided in Supplementary Table 2.
2.4. CFU-assay
Pre-G0 or G0 (MC culture) cells were used for CFU-f assay as pre-
viously described (Subramaniam et al., 2013). hBMSC (500 cells) or
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mBMSC (2000 cells) were plated in 100mm dishes in growth medium,
with medium replacement every third day. After 10 days, media was
removed; the dish washed with PBS and colonies stained with 2%
methylene blue (Sigma) solution (prepared in absolute ethanol) for
15min at room temperature. Dishes were washed under running water
to remove residual stain. Colonies were counted manually using ste-
reomicroscope.
2.5. Osteoblast and adipocyte diﬀerentiation
G0 (MC culture) cells were reactivated in growth medium for 24 h
(R24) before inducing diﬀerentiation. Osteoblast (OB) diﬀerentiation
was performed on cells plated at a density of 20,000/cm2. Osteogenic
induction media contained MEM supplemented with 10% FBS, 10mM
β-glycerophosphate (Sigma), 50 μg/ml L-ascorbic acid-2-phosphate
(Sigma), 10 nM dexamethasone (Sigma) and 10 nM 1,25 hydroxy-vi-
tamin D3 (Sigma) for 21 days, media were changed every 3 days.
Adipogenesis (AD) was induced on cells plated at 30,000/cm2 in media
containing 10% FBS, 10% horse serum, 450 μM 1-methyl-3-iso-
butylxanthine (IBMX, Sigma), 5 μg/ml insulin (Sigma) and 1 μM ro-
siglitazone (Cayman Chemical) for 15 days, media was replaced every
3 days. Alkaline phosphatase activity was measured as previously
published (Harkness et al., 2016).
2.6. Cytochemical staining
Staining was performed on cells undergoing osteogenic and adipo-
genic diﬀerentiation. Brieﬂy, osteogenesis was detected by ﬁxing cells
in ice cold 70% EtOH for 1 h at −20 °C, incubating in 40mM alizarin
red dye (pH 4.2) (AZR, Sigma), for 10 mins at RT, washed in water and
PBS to remove excess stain. For quantiﬁcation, AZR was eluted using
10% cetylpyridinium chloride (Sigma) and absorbance measured at
570 nm. Cells undergoing adipogenic diﬀerentiation were ﬁxed in 4%
formalin for 5 mins at RT, washed in 3% isopropanol and incubated
with 0.5% oil red O (ORO, Sigma) in 60% isopropanol for 1 h at RT.
Excess stain was removed by washing in water, ORO was eluted in
absolute isopropanol and quantiﬁed at 510 nm on a FLUOstar Omega
plate reader (BMG Labtech).
2.7. In vivo bone formation assay
Either pre-G0 or R24 hBMSC-TERT cells were used to perform
heterotopic bone formation assay according to protocol described pre-
viously (Abdallah et al., 2008). Brieﬂy, 500,000 cells (pre-G0 or R24)
were mixed with hydroxy-apatite/tricalcium phosphate ceramic
powder (HA/TCP, 40mg; Zimmer Scandinavia) and incubated over-
night at 37 °C in humidifying incubator. After, excess medium was re-
moved and HA/TCP with hBMSC-TERT cells was transplantation on
either side of the dorsolateral area of NOD/SCID mice. After 8 weeks,
implants were harvested and ﬁxed in 4% formaldehyde for 24 h, dec-
alciﬁed in formic acid for 3 days, and embedded in paraﬃn and sec-
tioned. Sections were and stained with haematoxylin & eosin. Bone
volume per total volume was blindly quantiﬁed using pixel scoring
method as described previously (Abdallah et al., 2008). Human-speciﬁc
vimentin staining (Thermo Scientiﬁc) was used to show that the cells in
the implants were of human origin.
2.8. RNA/DNA staining
Cells were incubated with 10 μm Hoechst 33,342 (Sigma) for 45
mins at 37 °C. Cell pellets were then washed in PBS before incubation
with 5 μM Pyronin Y (Sigma) with 0.1 μm Verapamil (Sigma; to inhibit
dye eﬄux) for 30–45min at 37 °C. Stained cells were collected on glass
slides using a cytospin and imaged.
2.9. Microarray analysis
RNA was isolated from pre-G0, G0 (MC culture) and 24 h re-
activated post-G0 (R24) hBMSC-TERT. Microarray processing was done
at Genotypic Inc. Bangalore, India, using Agilent 60 K human whole
genome gene expression arrays (one-colour array, experimental proto-
cols are available on http://www.agilent.com). The data was extracted
using Agilent Feature extraction software and analyzed using
GeneSpring GX version 11.5 and normalized using the 75th percentile
shift. Samples were compared as G0 vs Pre-G0, R24 vs G0 and R24 vs
Pre-G0. Genes 2-fold up- and down-regulated in test samples with re-
spect to controls were identiﬁed (Supplementary Table 3).
Diﬀerentially regulated genes during G0 and R24 were used to generate
PCA plot (ClustVis) and heatmap (Morpheus). Data was analyzed using
online tool DAVID (Huang da et al., 2009). MIAME-compliant micro-
array data is deposited in NCBI GEO (Accession # GSE60608).
2.10. Statistical tests
Data is represented as the mean ± SEM and derived from at least
three independent experiments. Graphs were produced using Microsoft
Excel or Graphpad Prism software and statistically analyzed using
Student's t-test.
3. Results
3.1. Modulation of cell adhesion induces BMSC to enter G0
In vitro, G0 or reversible cell cycle arrest is triggered by mitogen
depletion (Pardee, 1974; Sage et al., 2000), anchorage deprivation
(Macpherson and Montagnier, 1964, Benecke et al., 1978, Ben-Ze'ev
et al., 1980), inhibition of cytoskeletal signaling (Dhawan and Helfman,
2004) or growth to conﬂuence (Abercrombie, 1970). To generate G0
cultured BMSC, we modiﬁed protocols for suspension culture
(Milasincic et al., 1996; Sellathurai et al., 2013) and culture on soft
substrates (Winer et al., 2009) that have previously been described for
inducing G0 in ASC. In suspension culture, BMSC were anchorage de-
prived in a viscous medium containing 1.3% MC whereas on soft PAA
gels (0.6 kilopascal (kPa) stiﬀness) the cells were loosely attached and
unable to exert suﬃcient contractile force to spread (Fig. 1A). We tested
the proliferative behavior of hBMSC on PAA gels of varying stiﬀness
and identiﬁed lower stiﬀness gels (≤1 kPa) were eﬃcient in inhibiting
hBMSC proliferation as determined by bromodeoxyuridine (BrdU) in-
corporation (Fig. S1A). In addition, compared to hBMSC cultured on
stiﬀ PAA gels (40 kPa) that formed robust actin stress ﬁbers and focal
adhesions, hBMSC cultured on soft PAA gels (0.6 kPa) failed to form
stress ﬁbers and focal adhesions (Fig. S1B).
We tested the functional properties of BMSC derived from three
diﬀerent sources-primary human BMSC (hBMSC), primary mouse BMSC
(mBMSC) and a human telomerized BMSC cell line (hBMSC-TERT)
(Simonsen et al., 2002). We observed a signiﬁcant reduction in the
percentage of ki67-positive cells (indicative of cycling cells) when pri-
mary hBMSC were cultured in MC suspension (> 5-fold, p < 0.05) or
on soft PAA gels (> 3-fold, p < 0.05) (Fig. 1B). Similar results were
obtained when hBMSC-TERT were cultured in MC suspension, (> 5-
fold reduction in ki67 positive cells, p < 0.05) (Fig. S2A). Time course
analysis revealed a rapid decline in the number of proliferating cells as
early as 12 h following culture of hBMSC in MC suspension (Fig. 2A)
and on soft PAA gels (Fig. 2B) and minimal DNA synthesis was observed
after 48 h (Fig. 2A,B). Similar results were obtained with hBMSC-TERT
(Fig. S2B) and mBMSC (Fig. S3A).
To determine whether cell cycle arrest induced by MC and soft PAA
culture is reversible, BrdU incorporation was assessed after replating G0
arrested BMSC onto tissue culture plastic dishes. Replating of either MC
suspension- or soft PAA gel-cultured BMSC on plastic tissue culture
plastic dishes in growth medium (with 10% serum) led to synchronous
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cell cycle re-entry as evidenced by increased BrdU incorporation be-
ginning at 12 h of replating, with the number of labeled cells peaking
between 24 and 36 h (> 10-fold increase compared to G0 (48 h),
p < 0.05) (Fig. 2A,B). A similar trend was observed in hBMSC-TERT
(Fig. S2B) and mBMSC (Fig. S3A). These experiments demonstrate that
both human and mouse primary BMSC attain a reversible G0 state when
cultured in suspension or on soft gels.
3.2. Regulation of cell cycle genes during G0 entry and exit
We analyzed the expression of positive and negative regulators of
cell cycle in hBMSC during G0. Cyclin D1 (CCND1), an important
regulator of G1-S transition was down regulated in G0 arrested hBMSC
(> 2-fold, p < 0.05) (Fig. 3A). Similarly, the expression of cyclin A2
(CCNA2), cyclin B1 (CCNB1) and cyclin E1 (CCNE1) were down regu-
lated signiﬁcantly (p < 0.05) in G0 hBMSC (Fig. 3A). The marked in-
crease in CCNA2 and CCNE1 in 24 h reactivated (R24) cells compared
Fig. 1. G0 induction in BMSC.
(A) Methods to induce G0 in BMSC.
BMSC are maintained as asynchronous proliferating population (pre-G0) on tissue culture plastic dishes in growth medium. To induce G0 arrest, BMSC were cultured
for 48 h in suspension medium composed of 1.3% methylcellulose (MC culture) or cultured on soft polyacrylamide (PAA) gels (0.6 kPa). For reactivation, G0 arrested
cells were harvested and replated on tissue culture plastic dishes in growth medium.
(B) ki67 expression in pre-G0 and G0 arrested hBMSC.
Assessment of ki67 expression in hBMSC during pre-G0, G0 in MC and G0 on 0.6 kPa PAA gel; ki67 in green; DAPI in blue, *p < 0.05, scale bar= 100 μm.
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to pre-G0 cells reﬂects the synchronous nature of the population fol-
lowing a period in G0 (Fig. 3A). In addition, negative regulator of cell
cycle cyclin dependent kinase inhibitor (CKI)-p21 and p27 was strongly
up-regulated in G0 hBMSC (> 2-fold, p < 0.05) (Fig. 3A). During re-
activation (R24), the expression of the cyclins and CKI were restored
(> 2-fold change in expression, p < 0.05), conﬁrming the reversibility
of G0-associated changes in cell cycle gene program (Fig. 3A). Similar
results were obtained with hBMSC-TERT (Fig. S2C) and mBMSC (Fig.
S3B).
To examine whether induction of G0 in hBMSC aﬀects their self-
renewal, we determined colony-forming capacity before and after in-
duction of G0. G0 BMSC exhibited a signiﬁcantly increased number of
colony-forming unit-ﬁbroblast (CFU-f) compared to pre-G0 BMSC
(p < 0.05) (Figs. 3B, S3C).
Previous studies have reported that G0 in mammalian cells is as-
sociated with reversible suppression of RNA synthesis (Ben-Ze'ev et al.,
1980). To visualize RNA content in MC-cultured BMSC, we stained cells
with Pyronin-Y. As shown in Fig. S2D, global RNA content of G0
hBMSC-TERT was signiﬁcantly decreased as compared to pre-G0 cells
and restored during post-G0 reactivation (R24).
3.3. Diﬀerentiation capacity of BMSC following post-G0 reactivation
To address whether induction of G0 aﬀect diﬀerentiation capacity of
BMSC, we assessed adipocytic (AD) and osteoblastic diﬀerentiation
(OB) potential of pre-G0 and post-G0 reactivated (R24) hBMSC-TERT.
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Fig. 2. Kinetics of G0 entry and reactivation in hBMSC.
(A) Detection of BrdU incorporation in primary hBMSC during pre-G0, G0 entry in MC and reactivation, R (hours) (B) Detection of BrdU incorporation in primary
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We observed signiﬁcantly increased gene expression levels of osteo-
blastic genes-osteopontin (OPN), RUNX2, and alkaline phosphatase
(ALP) (OB day 7) (Fig. 4A), increased ALP activity (OB day 7) (Fig. 4B)
and increased mineralized matrix formation (OB day 14) (Fig. 4C) in
R24 reactivated cells. To determine whether the in vitro enhanced os-
teoblast diﬀerentiation ability of reactivated hBMSC-TERT coincides
with bone formation in vivo, we tested the ectopic bone formation
ability of R24 cells. Indeed, R24 hBMSC-TERT cells display an increased
ability to form bone in an ectopic model of bone formation (n=4,
p < 0.05) (Fig. 4D). By contrast, adipocyte diﬀerentiation was com-
promised, as upon AD induction, R24 hBMSC-TERT exhibited lower
adipocyte diﬀerentiation capacity, evidenced by lower gene expression
levels of PPARγ, adiponectin (adipoQ) and adipocyte protein-2 (aP2)
(AD day 7) (Fig. 4E) and less oil droplets accumulation (AD day 14)
(Fig. 4F).
3.4. Global gene expression proﬁle of G0 and reactivated hBMSC
To explore global changes in gene expression associated with in-
duction of G0 and post-G0 reactivation (R), we performed gene ex-
pression proﬁling of hBMSC-TERT in the following conditions: pre-G0
(asynchronously proliferating), G0 (cell cycle arrested following 48 h in
MC) and 24 h reactivated post-G0 (R24). Principle component analysis
(PCA) demonstrated clear clustering of sample replicates at each time
point demonstrating reproducibility of the data and induction of a
speciﬁc genetic program (Fig. 5A).
To visualize co-regulated genes during G0 and reactivation, we
generated a heatmap of diﬀerentially regulated genes in three condi-
tions (pre-G, G0 & R24) that revealed two categories of co-regulated
genes (1) genes suppressed during G0 and (2) genes induced in G0
(Fig. 5B). In addition, heatmap showed that changes in gene expression
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Fig. 3. G0 entry and exit in hBMSC.
(A) Detection of levels of cyclins (CCNA2, CCNB1, CCND1, CCNE1) & CKIs (p21 & p27) during pre-G0, G0 (MC culture) and R24 (reactivation 24 h) by qRT-PCR (B)
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induced during G0 are not completely reversible within 24 h of re-
activation (R24), suggesting that the molecular changes during G0 exert
long-term eﬀects on cellular phenotype. During G0, 5069 genes were
diﬀerentially regulated (> 2-fold up or down regulated) as compared to
pre-G0 cells (Fig. 5C). At 24-h reactivation (R24), we observed 5084
genes diﬀerentially regulated (> 2-fold up or down regulated) as
compared to G0 cells (Fig. 5C). Interestingly, comparing molecular
signature of reactivated sample R24 with pre-G0 proliferating cells,
revealed signiﬁcant diﬀerences with 4443 genes (> 2-fold up or down
regulated) diﬀerentially regulated (Fig. 5C), consistent with retention
of population synchrony following cell cycle re-entry.
To classify the diﬀerentially expressed genes during G0, we per-
formed gene ontology (GO) analysis using online tool DAVID. As ex-
pected, genes down-regulated in G0 were enriched in several categories
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related to cell division (KIFC1, CCNE2, CDC42, CCNA2, CDC6, FBXO5,
CCNB1, CCNB2) and DNA replication (CLSPN, DBF4, TIPIN, POLA2). In
muscle stem cells, it has been shown that G0 state is associated with
suppressed protein synthesis (Zismanov et al., 2016). Interestingly, we
also observed down regulation of genes regulating translation/transla-
tion initiation (MRPS36, RPL17, RPL36A, MRPS33, MRPS14, ABCE1,
RPL17, RPL36A) suggesting global suppression of translation in G0
hBMSC-TERT. Suppression of genes regulating nuclear-transcribed
mRNA catabolic process (RPL17, RPL36A, RPL35, RPS15A, RPL23A)
suggest an increase mRNA turnover in G0 hBMSC-TERT cells (Fig. 5D).
Genes upregulated in G0 hBMSC-TERT cells suggest an enhanced
osteogenic potential of these cells as they were enriched for ontology
(GO) terms including osteoblast diﬀerentiation (IBSP, BMP2, ITGA11,
WNT11, SPP1, BMP6, TWIST1), extracellular matrix organization
(ITGA10, ITGB3, LAMB3, ITGAX, COL7A1) and response to vitamin D
(STC2, PTGS2, STC1, CD4, BMP7, SPP1). Further, upregulation of genes
regulating angiogenesis (SAT1, FGF18, VEGFA, PECAM1, HIF3A) and
inﬂammatory response (PTSG2, IL10, IL1A. IL1B, CCR7) in G0 hBMSC-
TERT cells suggest a distinct paracrine activity of these cells (Fig. 5E).
Relevant pathways enriched in G0 hBMSC-TERT are depicted in
Fig. 6A, important pathways include metabolic pathways (AUH, AMY1C,
IMPA2, GAA, TK2, PTGS1), regulation of actin-cytoskeleton (PXN, ITGB3,
ITGAX, PIK3R2, ITGA11, ITGA10), TGF-beta signaling pathway (BMP8B,
BMP2, SMAD7, BMP7, BMP6, ID2, ID1, ID4, ID3, THBS2) and Wnt-
Fig. 5. Gene expression proﬁling of pre-G0, G0 (MC culture) and reactivated (R24) hBMSC-TERT using microarrays.
(A) PCA plot depicting transcriptome of samples used in the study (pre-G0, G0 & R24), (B) heat map depicting co-regulated genes in G0 and R24, (C) number of
diﬀerentially regulated genes (> 2-fold), (D&E) gene ontology (GO) term enriched in signiﬁcant down regulated and up regulated genes during G0.
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signaling pathway (AXIN2, WNT7B, FZD8, WNT5A, WNT11,). Due to
their relevance to hBMSC biology, we chose several BMP signaling
genes that were upregulated during G0 to validate by qRT-PCR. As seen
in Fig. 6B there was a good correlation between microarray results and
qRT-PCR.
3.5. Eﬀect of G0 on hBMSC paracrine factors expression
Clinical transplantation of BMSC has been employed to enhance
tissue regeneration in a number of clinical conditions, as they secrete a
large number of bio-active molecules with possible anti-inﬂammatory,
tissue protective or regenerative eﬀects (Vizoso et al., 2017). To de-
termine the proﬁle of therapeutically relevant secreted factors, we
mined the microarray data to reveal the eﬀects of reversible G0 on gene
expression of BMSC secreted factors. Several known MSC derived
paracrine factors were signiﬁcantly up-regulated during G0 (> 2-fold)
including interleukin receptor 1 antagonist (IL1RN) (Ortiz et al., 2007),
stanniocalcin 1 (STC1) (Bartosh et al., 2010), interleukin 10 (IL10)
(Choi et al., 2008), placental growth factor (PGF) (Marrony et al.,
2003), vascular endothelial growth factor A (VEGFA) (Matsumoto
et al., 2005), leukemia inhibitory factor (LIF) (Nasef et al., 2008), in-
terleukin 8 (IL8) (Kim et al., 2009), c-x-c motif chemokine ligand 3
(CXCL3) (Lee et al., 2012) and amphiregulin (AREG) (Kerpedjieva
et al., 2012) and these changes were validated using qRT-PCR (Fig. 6C).
4. Discussion
Several studies have suggested that a subpopulation of BMSC are in
Fig. 6. Pathways and paracrine factors in G0 (MC culture) hBMSC-TERT.
(A) Pie chart representing fraction of genes of particular pathways enriched in G0 hBMSC-TERT, (B) representative genes enriched in TGF beta/BMP signaling
pathway in microarray & validated by qPCR, (C) expression of paracrine factors-PGF, VEGFA, LIF, IL1RN, IL10, STC1, IL8, CXCL3, and AREG in pre-G0, G0 and R24
hBMSC-TERT in microarray & validated by qPCR.
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G0 state within the in vivo niche (Peiﬀer et al., 2007; Morikawa et al.,
2009); however, an explicit analysis of G0 biology has not been re-
ported. Here, we report a detailed cellular and molecular phenotypic
characterization of the G0 state in hBMSC. First, we report two simple
and eﬃcient methods for generating homogeneous populations of G0
BMSC based on changing cellular adhesive properties through culturing
in viscous medium or on soft substrates. Second, we extensively char-
acterize this cellular state. Finally, we demonstrate that by passage
through a G0 state, BMSC acquire enhanced potential for clonogenic
self-renewal (CFU-f) and osteoblastic diﬀerentiation, both in vitro and
in vivo.
Cultured mammalian cells can be induced to enter G0 state by
manipulating variables that are necessary for active proliferation such
as contact inhibition (Macpherson and Montagnier, 1964, Philips et al.,
1999) or mitogen-deprivation (Gustincich and Schneider, 1993).
However, previous studies have reported that contact inhibition is in-
eﬃcient in suppressing hBMSC proliferation (Oskowitz et al., 2011) and
that mitogen-deprivation induces early replicative senescence (Ho
et al., 2011). Alternatively, modulating adhesion-dependent signaling
pathways either by complete deprivation of cell anchorage using sus-
pension culture in methylcellulose (MC) (Milasincic et al., 1996) or by
direct inhibition of actomyosin contractility using small molecule in-
hibitors (Dhawan and Helfman, 2004) have been used to induce G0,
even in mitogen-rich media. We observed that both suspension culture
in MC or plating on soft PAA substrates were eﬃcient in inducing G0
state in BMSC. For G0 induction, MC culture is advantageous over PAA
as preparation of the viscous medium is simple and large number of
homogenous quiescent cells can be generated in relatively less volume
(one million cells per 10ml of MC suspension). One of the major dis-
advantage of MC culture is that it is not possible to replenish the culture
medium therefore cell cannot survive once the nutrients are exhausted.
We observed that induction of G0 in BMSC led to signiﬁcant changes
in cellular and molecular phenotype. This corroborates our previous
ﬁndings in other cultured cell types (Sellathurai et al., 2013;
Subramaniam et al., 2013). The G0 state has been shown in freshly
isolated HSC and muscle stem cells to promote tolerance of prolifera-
tion-associated genetic stresses, protection from cytotoxic agents and
preservation of genome integrity, due to low probability of in-
corporating deleterious mutations (Pallafacchina et al., 2010; Mourikis
et al., 2012). The biological importance of G0 state can also be gauged
from reports that associate loss of quiescence with accelerated aging
(Sousa-Victor et al., 2014, Mendelsohn and Larrick, 2016) and patho-
logical cellular changes (Cheung and Rando, 2013).
Induction of G0 in BMSC led to decreased DNA synthesis, repressed
global RNA levels, decreased expression of cyclins, and increased ex-
pression of CKI. These data are similar to the reported characteristics of
G0 mouse ﬁbroblasts and human myoblasts (Sellathurai et al., 2013;
Subramaniam et al., 2013) and demonstrate the universal nature the G0
phenotype. Interestingly, similar to primary hBMSC, the immortalized
hBMSC-TERT cell line (Simonsen et al., 2002), despite expression of
high level of telomerase activity responded to anchorage deprivation
suggesting retention of tumor suppressive mechanisms of anchorage-
dependence.
Most studies examining the biology of BMSC employed asynchro-
nized proliferating cultures that may not reﬂect critical aspects of the in
vivo biology of these adult stem cells, our data provide some insight
into these diﬀerences. For example, we found that the transcriptome of
G0 hBMSC was markedly diﬀerent from that of asynchronized pro-
liferating (pre-G0) hBMSC and the genes reversibly suppressed during
G0 were cell cycle regulators as has been reported in other cell types
including myoblasts and ﬁbroblasts (Sachidanandan et al., 2002). Dif-
ferences in gene expression of pre-G0 and reactivated R24 cells were
intriguing, even though both samples were adherent and cycling. It is
well known that G0-synchronized cells exhibit extended kinetics of
entry into S phase compared to asynchronously proliferating cells
(Coller, 2007) and this observation supports the idea that the ﬁrst cell
cycle following G0 is distinct from subsequent cycles when exponential
cell kinetics are restored. Also, previous studies have demonstrated that
the ﬁrst cell cycle following G0 is distinct from subsequent cycles as
duration of G1 phase of ﬁrst cell-cycle after G0 is considerably larger
(Coller, 2007).
G0 is usually associated with reversible suppression of lineage-
speciﬁc gene expression (Milasincic et al., 1996, Dhawan and Helfman,
2004), suggesting that this cellular state promotes self-renewal. We
observed that induction of G0 in hBMSC led to shift in lineage fate
choice with increased capacity for osteoblast diﬀerentiation and de-
creased adipocyte diﬀerentiation. It might be possible that MC culture
select for pre-osteoblastic cells at the expense of pre-adipocytic cells
(Post et al., 2008). However, we did not observe severe change in cell
number or cell death following G0 culture, making this explanation
improbable. It is also possible that induction of G0 may enhance epi-
genetic imprinting of the tissue of origin, which, for hBMSC is osteo-
genic. In support of this concept, we found enhanced expression of
known positive modulators of TGFβ/BMP signaling pathway during G0
and R24. BMP signaling is important for osteoblast diﬀerentiation as
demonstrated by several in vitro studies that reported that BMP-2,
BMP-6 and BMP-7 enhance osteoblast diﬀerentiation of hBMSC (Peng
et al., 2004; Sammons et al., 2004; Ho et al., 2016). Downstream ef-
fectors of BMP-signaling, the helix-loop-helix proteins-inhibitor of DNA
binding/diﬀerentiation (Id), mediate BMP-induced osteoblast diﬀer-
entiation of BMSC (Peng et al., 2004). BMP9 stimulation of MSC en-
hances gene expression of Id1, Id2 and Id3 and induces osteoblastic
diﬀerentiation (Peng et al., 2004). On the other hand, loss of Id proteins
diminishes BMP9 induced osteogenic diﬀerentiation in MSC (Peng
et al., 2004). In accordance, we found enhanced expression of Id1, Id2,
Id3 and Id4 during G0 and in post-G0 reactivated (R24) hBMSC-TERT.
Previous studies showed a role of Wnt-signaling in regulating G0 state
in muscle stem cells (Sellathurai et al., 2013; Subramaniam et al.,
2013). Our study supports these previous observations as components
of Wnt-signaling were induced in G0 hBMSC-TERT.
The enhanced expression of transcripts encoding therapeutically
relevant secreted factors including growth factors (VEGFA, PGF, LIF),
anti-inﬂammatory (IL1RN, IL10, STC1) and chemokines (IL8, CXCL3,
AREG) in G0 hBMSC-TERT cells suggests an altered secretome and
important changes in paracrine signaling. BMSC-derived VEGFA is
known to enhance neovascularization in animal model of myocardial
infarction (Matsumoto et al., 2005), while BMSC-derived PGF might
play a role in angiogenesis and hematopoiesis (Marrony et al., 2003).
The anti-inﬂammatory role of BMSC-derived IL1RN and IL10 has been
shown in animal model of lung injury and arthritis respectively (Ortiz
et al., 2007; Choi et al., 2008).
Quiescent cells are reported to be highly metabolically active de-
spite being non-dividing (Lemons et al., 2010) and exhibit increased
glycolysis, which is a hallmark of self-renewal in stem cells (Shyh-
Chang et al., 2013). Enrichment of metabolic pathways in our tran-
scriptome analysis of G0 BMSC supports this observation and might
explain increased self-renewal ability of the cells post-G0. In one pre-
vious study, Witkowska et al., have shown that osteoblastic diﬀer-
entiation of BMSC was enhanced when cultured on stiﬀ compared to
soft PAA substrates (Witkowska-Zimny et al., 2013). However, the soft
PAA employed in that report was much stiﬀer (1.46 kPA) than the one
used in our study (0.6 kPA), which was reﬂected as continued pro-
liferation evidenced by increased cell number (Witkowska-Zimny et al.,
2013). In our experiments, we also employed a low seeding density on
soft PAA, which prevented cell-cell contact (Venugopal et al., 2018),
and together resulted in induction of G0. Thus, the changes we report in
BMSC biology were not dependent on external mechanical determi-
nants of the PAA gel but on the induction of the G0 state by the altered
contractility experienced by cells.
Our study does not address some important issues that are avenues
for future investigation. Since the culture conditions in vitro do not
reﬂect the in vivo environment, further studies are required to assess
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how closely the molecular phenotype can be extrapolated to BMSC in
vivo. Also, while we could show that BMSC reprogrammed into the G0
state in culture exhibit enhanced bone formation capacity in vivo, the
therapeutic relevance of our ﬁndings need conﬁrmation employing in
vivo bone regeneration models. Further, using the current culture
condition, we cannot exclude that part of the observed changes in the
molecular phenotype of BMSC induced to enter G0 was caused by
material cues irrespective of G0 state (Crowder et al., 2016). However,
our earlier studies in myoblasts show that perturbation of either ad-
hesion or mechanical cues converges on signaling pathways that lead a
cell into quiescence (Dhawan and Helfman, 2004, Gopinath et al.,
2007). Induction of G0 by diﬀerent methods (contact inhibition, loss of
adhesion and mitogen deprivation) is associated with a characteristic
molecular phenotype irrespective of the material cues as demonstrated
in ﬁbroblasts (Coller et al., 2006) by transcriptional proﬁling. Finally,
cell surface markers from our G0 transcriptome data could be used to
validate or purify mononuclear cells from the bone marrow, and G0
BMSC could also be tested in animal models for their eﬃcacy in disease
models.
5. Conclusion
Methylcellulose culture and soft substrate culture methods are ef-
ﬁcient to induce G0 state in BMSC. Induction of G0 state in BMSC en-
hances stemness-phenotype including clonogenic self-renewal and os-
teoblastic diﬀerentiation and in vivo ectopic bone formation. These
ﬁndings are relevant for future studies addressing aspects of the in vivo
biology of BMSC and may provide a simple method for improving
“BMSC functional cell quality” needed for therapeutic BMSC trials in
regenerative medicine.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.scr.2018.05.010.
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